Description

This guidance document provides sponsors of subsequent entry inhaled corticosteroid (ICS) products for the treatment of asthma with information on the comparative clinical data requirements in order to establish the safety and effectiveness of their products under Section C.08 of the Food and Drug Regulations.

Resources

Name	Format	Description	Link
Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/inhaled-corticosteroid-notice.html
Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-corticosteroides-inhales.html

Tags

Topics

Categories